the Effect of Diane-35 Pretreatment on In-vitro Fertilization Outcome for Patients With Polycystic Ovary Syndrome
Launched by FIRST AFFILIATED HOSPITAL, SUN YAT-SEN UNIVERSITY · Dec 16, 2012
Trial Information
Current as of May 07, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • diagnosed polycystic ovary syndrome patients according to Rotterdam criteria
- • with hyperandrogenism and/or clinical hyperandrogenic manifestations
- • no other oral contraceptives treatment for at least 3 months before this experiment
- • no any other assisted reproductive therapy
- • accompanied with fallopian tube and/or male factors
- • normal hepato-/nephro- function
- Exclusion Criteria:
- • oral contraceptive pills contraindications, eg.Deep Venous Thrombosis
- • smoking, drunk
- • exclude other infertile factors, eg.endometriosis, abnormal thyroid function, etc.
About First Affiliated Hospital, Sun Yat Sen University
The First Affiliated Hospital of Sun Yat-sen University is a prestigious medical institution located in Guangzhou, China, renowned for its commitment to advancing healthcare through innovative clinical research and comprehensive patient care. As a leading teaching hospital, it combines clinical excellence with academic rigor, facilitating a wide range of clinical trials across various specialties. The hospital is dedicated to improving health outcomes and contributing to medical knowledge, leveraging its state-of-the-art facilities and a team of highly qualified professionals to conduct high-quality research that adheres to international standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, Guangdong, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials